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Abstract
We modified the isolation procedure of muscle and heart mitochondria. In human muscle, this resulted in a 3.4 fold higher
yield of better coupled mitochondria in half the isolation time. In a preparation from rat muscle we studied factors that affected
the stability of oxidative phosphorylation (oxphos) and found that it decreased by shaking the preparation on a Vortex ma-
chine, by exposure to light and by an increase in storage temperature. The decay was found to be different for each substrate
tested. The oxidation of ascorbate was most stable and less sensitive to the treatments.
When mitochondria were stored in the dark and the cold, the decrease in oxidative phosphorylation followed first order ki-
netics. In individual preparations of muscle and heart mitochondria, protection of oxidative phosphorylation was found by
adding candidate stabilizers, such as desferrioxamine, lazaroids, taurine, carnitine, phosphocreatine, N-acetylcysteine, Trolox-
C and ruthenium red, implying a role for reactive oxygen species and calcium-ions in the in vitro damage at low temperature
to oxidative phosphorylation.
In heart mitochondria oxphos with pyruvate and palmitoylcarnitine was most labile followed by glutamate, succinate and
ascorbate. We studied the effect of taurine, hypotaurine, carnitine, and desferrioxamine on the decay of oxphos with these
substrates. 1 mM taurine (n = 6) caused a significant protection of oxphos with pyruvate, glutamate and palmitoylcarnitine,
but not with the other substrates. 5 mM L-carnitine (n = 6), 1 mM hypotaurine (n = 3) and 0.1 mM desferrioxamine (n = 3) did
not protect oxphos with any of the substrates at a significant level.
These experiments were undertaken in the hope that the in vitro stabilizers can be used in future treatment of patients with
defects in oxidative phosphorylation. (Mol Cell Biochem 174: 61–66, 1997)
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Introduction
The study of oxidative phosphorylation in intact mitochondria
provides important information on the integrity of the mito-
chondrial transporters, dehydrogenases and the respiratory
chain complexes, of the coupling between oxidation and phos-
phorylation and of the efficiency of the energy transduction.
The aim of the present investigation was to study the sta-
bility of oxidative phosphorylation catalyzed by muscle mi-
tochondria obtained with a new isolation procedure. We tried
to improve the storage and handling conditions, and studied
the effect of the addition of potential stabilizing agents.
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Materials and methods
Human and animal muscle
Human muscle was obtained under local analgesia from the
M. vastus lateralis of patients and controls. The stability was
studied of mitochondrial preparations with a normal oxidation
rate of pyruvate plus malate, determined directly after isola-
tion in the range of 52–140 nmol O2·min–1·(mg protein)–1. To
determine the decay, the assay of pyruvate plus malate oxi-
dation was repeated after about 2.5 h. For the calculation of
the decay see below. Since there was no statistical difference
between the decay of pyruvate oxidation in the patients and
the controls, they were taken together.
Masseter muscle and heart muscle were taken from nor-
mally fed male Wistar rats of 14 weeks, weighing 180–210
g. The animals were anesthetized with a mixture of ether and
air, and killed by decapitation in the morning.
Chemicals
N-Acetyl-L-cysteine, desferrioxamine mesylate, hypotaurine,
rotenone and ruthenium red were from Sigma, L-carnitine
from Lonza, lazaroids U-74389F and U-74500A from
Upjohn, palmitoyl-L-carnitine from Fluka, phosphocreatine
and hexokinase from Boehringer Mannheim, taurine from
BDH and trolox-C (vitamin E without side chain) from
Aldrich. The other chemicals used were of the highest pu-
rity available.
Isolation of mitochondria
Rapid isolation of muscle mitochondria in high yield was
based upon Bookelman et al. [11], which on its turn was
based upon Luft et al. [21] and Dow [3]. We modified the
mincing of the muscle and used shorter centrifugation times
at higher forces. This method is suitable for heart and mus-
cle mitochondria, but not for liver mitochondria, which are de-
stroyed by the heparin in the isolation medium. In the past it
was found that pretreatment with digitonin stabilized rat liver
mitochondria by removing the lysosomes [4]. This treatment
was also successful in removing lysosomes from muscle mi-
tochondria, but failed to increase their stability (not shown).
The time required for the isolation was 1 h at a tempera-
ture of 0°C. The average yield from human muscle deter-
mined by the assay of citrate synthetase in the homogenate
and in the mitochondrial preparation was 42%. In our hands
the method of Bookelman et al. [1] gave rise to an average
yield of 12.4% and the isolation took more than 2 h.
The isolation medium was the so-called SETH-medium,
containing 250 mM sucrose, 2 mM EDTA, 10 mM Tris-HCl,
50 U/ml heparin, pH 7.4. For homogenisation, tightly fit-
ting Potter-Elvehjem glass homogenisers were used, with
a Teflon pestle driven by a motor at 800 rpm (homogenate),
or by hand power (mitochondrial fraction). One stroke is
down- plus upwards.
The centrifuge used was of Beckmann, type J2-21 with the
JA 20 rotor containing 10 ml Pyrex tubes with r
max 
of 10.3 cm
and r
min of 4.4 cm. The brake setting was maximal. The cen-
trifugation of Bookelman et al. [1] with minimal brake setting
was followed with time, and the sedimentation coefficients in
Svedberg units were calculated by the use of the formula of
De Duve and Berthet [5] to enable recalculation of reproduc-
ible spins at higher speeds in shorter time. In spite of the
maximal brake setting, now the acceleration/deceleration
phases of the spins gave a much higher contribution to the
sedimentation coefficients. The low speed spin was for 1 min
at 7000 rpm, corresponding to 4200 g
av
 and the high speed
spin for 1.5 min at 18000 rpm (27500 g
av
).
The isolation procedure, summarized in Fig. 1 is as fol-
lows: (1) Biopsy of patients suspected of having a mitochon-
drial disease from the M. vastus lateralis under local analgesia.
Male Wistar rats are anaesthetized with a mixture of ether and
air, and decapitated. The masseter muscles and heart are used
for the experiments; (2) Transport the muscle in icecold
SETH-medium; (3) Dry the tissue with paper and weigh it
in a glass beaker. Minimal amount required is 80 mg; (4) Add
1 µl SETH-medium per mg of muscle and mince the muscle
by cutting it for 90 times with a pair of scissors by hand; (5)
Put the minced muscle with 18 µl medium/mg muscle into
the homogenizer tube and homogenize by 12 strokes; (6)
Sample this 5% homogenate to assay citrate synthetase by
the method of Srere [6]. The sample may be frozen, but then
the latency of the enzyme, which is a measure for the integ-
rity of the inner mitochondrial membranes cannot be deter-
mined; (7) 1st low speed spin. Poor out supernatant in another
tube. Transfer pellet with 19 µl medium/mg muscle into the
homogenizer tube and homogenize by 12 strokes; (8) 2nd low
speed spin. Repeat step 7; (9) 3rd low speed spin. Combine
supernatants of steps 7–9 for step 10; (10) lst high speed spin.
Remove supernatant with a pipette. Transfer pellet with 19
µl medium/mg of muscle into a smaller homogenizer, homog-
enize by 5 strokes by hand and transfer the preparation to a
centrifuge tube; (11) 2nd high speed spin. Transfer pellet with
19 µl medium/mg muscle into homogenizer and bring the
volume to 800 µl. After 5 strokes by hand the mitochondrial
fraction is obtained; (12) Sample to assay citrate synthetase
(CS) and protein. The total amount of mitochondria in the
homogenate in mg mitochondrial protein/g muscle with the
same purity as the isolated mitochondria can be calculated by
CS homogenate(U/g muscle)/CS mitochondria(U/mg protein).
For another approach to isolate and study pigeon breast
muscle mitochondria we refer to the work by HN Rasmusssen
and UF Rasmussen in the next paper.
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Assay of oxidative phosphorylation
Oxidative phosphorylation was measured by a Clark elec-
trode with a very small Pt surface, requiring powerful elec-
tronics for amplification of the relatively small signal [7]. The
advantage of this is that the stirring is not very critical. The
double wanded glass oxygraph vessel was of the traditional
type, but smaller, with a volume of 0.4 ml. The membrane
of the Clark electrode was the thinnest available. The iron
stirring rod was surrounded by glass, and driven by a simple
magnet stirrer. The oxidative phosphorylation (oxphos) me-
dium contained 5 mM potassium phosphate, 10 mM Tris-HCl,
100 mM KCl, 5 mM MgCl2, 5 µM EDTA, 75 mM mannitol,
25 mM sucrose, 15 mM glucose, 0.2 mg FA-free bovine se-
rum albumine (pH 7.4). Further additions were 20 µg hexoki-
nase, mitochondria, oxidative substrate, after steady state (5
min) 0.2 mM ADP (pH 7.4). The temperature was 37°C and
the volume 400 µl [8, 9]. The mitochondrial substrates tested
were 5 mM pyruvate + 2.5 mM L-malate, 5 mM glutamate +
2.5 mM L-malate, 20 µM palmitoylcarnitine + 0.6 mM L-
malate, 5 mM succinate + 3 µM rotenone, 5 mM ascorbate +
0.6 mM N,N,N′,N′-tetramethyl-p-phenylenediamine, TMPD
+ 0.1 mM desferrioxamine. For the determination of ATP, the
produced glucose-6-phosphate was determined in perchloric
acid deproteinized samples taken before and 10–20 min af-
ter the addition of the ADP [10].
The oxidation of ascorbate is complicated by the iron-
catalyzed auto-oxidation of ascorbate. The auto-oxidation
was considerably decreased by the addition of the iron-che-
lator desferrioxamine. There is however still some auto-oxi-
dation, which was experimentally determined at different
oxygen concentrations, and subtracted from the oxygen up-
take rate.
Calculations
In mitochondria stored in the cold and the dark, the decay of
oxidative phosphorylation measured as oxygen uptake with
the different substrates measured in the presence of ADP,
assayed at different occasions during several days, followed
first order kinetics. The decay was expressed in the first or-
der rate constant k in d–1, which is proportional to the rate of
the decay. The k was calculated from the oxygen uptake rate
J1 measured at the time t1 (in d) and J2 at t2 according to k =
(ln J2 – ln J1). (t2 – t1)–1, and from more points by regression
analysis between ln J and t. The half life time is equal to ln
2/k. In order to compare the results of the different experi-
ments, we assumed first order kinetics in all experiments.
Statistical analysis was performed by the paired two tailed
Students t-test. p values of less than 0.05 were considered sig-
nificant.
Results
Isolated mitochondria are labile. When stored under the same
conditions as during our routine experiments, the decay of
the oxidation of pyruvate in human mitochondria is about
twice as high as in rat masseter muscle mitochondria (Table
1). In human muscle mitochondria the rate of the decay var-
ied 20 fold. The most labile preparation had a half life of 1.21
h, was of a 17 year old boy with low respiratory control, and
the most stable one with a half life of 23 h was that of a 90
year old, well-trained lady who had a cardiac septum defect.
Her oxidative phosphorylation characteristics were in the
range of (younger) controls.
Storage of the rat masseter muscle mitochondria in the
dark, with minimal shaking (3 sec) on a Vortex machine, de-
creased the average decay in pyruvate (plus malate) oxidation
Fig. 1. Isolation scheme of heart and skeletal muscle mitochondria from
5% homogenate to the mitochondrial fraction. [Pellet] and [Supernatant]
means that these fractions were discarded.
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Table 2. Decay of oxidative phosphorylation in by rat masseter muscle
mitochondria. Effect of temperature, exposure to light and shaking
 Temp Light Vortex Pyruvate Glutamate Ascorbate
+ malate + malate + TMPD
6 – – 1.08 ; 1.38 0.02; 0.01 0.30 ; 000
23 – – 2.76 > 4.7 0.34
6 + – 1.51; 1.64 0.36 ; 0.45 0.37 ; 0.33
23 + – > 2.8 > 4.7 0.52
0 ++ – 4.42 ; 4.39 0.00 ; 0.00 0.00 ; 040
0 ++ + ; ++ 5.45 ; 14.3 3.46 ; 8.90 0.00 ; 6.24
Oxygen uptake rates were measured by a substrate inhibitor method. The
oxidation of pyruvate + malate (+ ADP) was inhibited after reaching steady
state by 1 mM α-cyano-3-OH-cinnamate, then glutamate was added and
complex I inhibited by 2 mM amytal, then ascorbate + TMPD + deferoxamine
were added. The results are given of two independent experiments. The
preincubation at 23°C was not performed in the second experiment. The
assays were performed directly after isolation and after 4 h for the 2 lowest
lines and after 22–28 h for the other experiments. Decay was expressed in
k(d–1), assuming first order kinetics of the decay. In case of k >, the oxygen
uptake rate became zero. Light: – is in the dark, + is the light in the cold
room (regular fluorescence tube 58 W, 55 Hz, Philips with cap, distance
1.1 m), cups in rack, ++ is the light in the laboratory [high frequency( 30
kHz) fluorescence tube 58 W, colour 84 without cap, distance nearest tube
2 m, second one 2.5 m] plus daylight from the window (1 × 1.5 m, no
direct sunlight, distance 3.2 m ), cups on ice. Vortex: – is not shaken, + is
shaken for 20 sec, ++ is shaken for 1 min. The concentration of mitochondrial
protein in the first experiment was 1.5 mg/ml, and 4.8 mg/ml in the second
one. The lowest line, with moderate shaking (+) reflects our previous
standard conditions in measuring oxidative phosphorylation (see Table 1).
Table 3. Mode of action of candidate mitochondrial stabilizers
N-Acetylcysteine FRS, precursor glutathione
L-Carnitine Acyl carrier, membrane stabilizer (11)
Desferrioxamine Ferri-chelator (12–15)
Hypotaurine FRS, decreases low O2-levels in tissue (16, 17)
Lazaroids Prevent iron catalyzed lipid peroxidation (18, 19)
Phosphocreatine ATP  regenerator
Ruthenium red Mitochondrial Ca2+-channel blocker
Taurine FRS, membrane stabilizer (16, 17)
Trolox-C FRS
FRS = Free radical scavenger.
by a factor 7 (Table 1). We studied the effects of exposure to
light, higher temperature and shaking on the oxidative phos-
phorylation by rat muscle mitochondria (Table 2) and found
that the glutamate oxidation was destroyed by increasing the
storage temperature from 6–23°C. That of pyruvate was de-
stroyed by a similar increase of the temperature plus the light
in the cold room. Pyruvate oxidation was found to be more
affected than glutamate oxidation by the more intense light
in the laboratory. Surprisingly, the oxidation of ascorbate was
only slightly affected by the exposure to the higher tempera-
ture and the light. The conditions routinely used to measure
oxidative phosphorylation, including exposure to light and
shaking was particularly damaging for the oxidation of pyru-
vate, but not for the oxidation of glutamate and ascorbate.
Prolonged shaking, however, was also found to be harmful
for the latter oxidations. The decay of oxidative phosphor-
ylation in the further experiments was studied in mitochon-
dria that had been stored in the dark and in the cold.
Table 3 summarizes the candidate agents to stabilize
oxidative phosphorylation used in this work. We studied the
decay of the oxidation of pyruvate + malate and of succinate
+ rotenone by muscle and heart mitochondria, and the effect
of the possible stabilizers during several days. Table 4 gives
an example of such an experiment. The decays followed first
order kinetics. The additions had no acute effect on the
oxidative phosphorylation. In this experiment 0.5 mM
desferrioxamine proved to be the best stabilizer, followed by
5 µg/ml of the lazaroid U-74389F, 0.5 mM N-acetylcysteine,
50 µM desferrioxamine, 2.5 mM Trolox-C, 2.5 mM L-car-
nitine, 5 mM Taurine, 1 mM Taurine, 1.25 µM ruthenium red,
7.5 mM phosphocreatine, while 50 µg/ml of the lazaroid U-
74500A did not protect. The addition of albumin had no ef-
fect on the decay (not shown). In one experiment the most
effective protector was found to be 1 mM taurine and in an-
other the lazaroids. These experiments suggested that the
phenomenon of stabilization showed a poor reproducibility
Table 1. Decay of oxidative phosphorylation with pyruvate plus malate
by isolated mitochondria
Muscle J
o 
(nmol O2·mm–1·mg–1) k(d–1) ± SD (range) n
mitochondria
A Human 82 ± 22 6.6 ± 4.1 (0.73–13.7) 21
A Rat masseter 258 ± 77 3.5 ± 1.9 (1.45–8.1) 15
B Rat masseter 142 ± 38 0.90 ± 0.39 (0.50–1.38) 5
The k was calculated from two assays and we assumed first order kinetics
of the decay. (A) Stored in transparent plastic cups on ice and shaken well
for a total period of ca 20 sec on a Vortex machine before sampling.
Oxidative phosphorylation was measured directly after isolation (J
o
) and
2.5 h later. (B) The mitochondria were stored in the dark at 6°C and were
shaken for 3 sec. Oxidative phosphorylation was measured directly after
isolation (J
o
) and after 1 day. Three of the preparations were followed longer
for several (3–5) days, and since a straight relation was obtained between
ln J and time (r = 0.96–0.98), the decay proved to obey first order kinetics.
The decays in the 3 preparations showed a statistically significant difference.
in different preparations.
To study this in more detail, we measured the decay of
oxidative phosphorylation with 5 different substrates in 6
independent preparations of rat heart mitochondria. In addi-
tion we studied the effects of taurine and carnitine, and of
hypotaurine and desferrioxamine in 3 of the preparations
(Table 5). In SETH-medium, the decay of oxidative phospho-
rylation with the NADH-dependent substrates (pyruvate,
glutamate and palmitoylcarnitine) was significantly different
from that with succinate and ascorbate. This suggests that
these couples of substrates share one vulnerable target. Likely
candidates for these targets are complex I for the NAD+-
linked substrates and complex IV for the latter couple. On
the average taurine retarded the decay of oxidative phospho-
rylation with pyruvate from 100 to 66%, glutamate to 83%,
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palmitoylcarnitine to 77%, (p < 0.05) succinate to 95% (NS)
and ascorbate to 93% (NS). For carnitine these percentages
were 89, 94, 88, 110 and 80% (all differences NS). Carnitine
exerted a protective effect on the oxidation of pyruvate and
palmitoylcarnitine in 5 of the 6 experiments, but did not reach
the preset level of significance. Hypotaurine and desferrio-
xamine did not protect significantly the decay of any of the
substrates tested. Desferrioxamine appeared to promote the
decay, especially with the substrates pyruvate (from 100–
181%) and palmitoylcarnitine (to 170 %).
Discussion
Isolated muscle mitochondria were found to be labile. And
our standard conditions for performing oxidative phosphor-
ylation were found to be damaging. Especially mixing the cup
with the isolated mitochondria on a Vortex machine and ex-
posure to light, even with the mitochondria on ice, damaged
oxidative phosphorylation. Oxidative phosphorylation with
the NAD+-linked substrates was more vulnerable than with
ascorbate. Fortunately we always tested oxidative phospho-
rylation in the order of pyruvate, glutamate, palmitoyl-
carnitine, succinate, ascorbate. So the most vulnerable
substrate oxidations were measured first. Nowadays we pro-
tect the isolated mitochondria from light by storage on ice in
amber plastic cups (Elkay Élreann, Galway, Fax: 353-91-
72309), and shake only for 3 sec before the assay.
Protection of oxidative phosphorylation could be realized
by a great variety of compounds with free radical scaveng-
ing properties, iron-chelators which inhibits the hydroxyl-
radical production by the Haber-Weiss reaction, membrane
stabilizers and an inhibitor of the calcium entry in mitochon-
dria. Because of the large variation in the lability and of the
improvement in stability by potential stabilizers between
individual preparations, large series are needed to confirm the
stabilizing action in an average preparation. In such experi-
ments with rat heart mitochondria, taurine was found to be
the best stabilizer of the oxidative phosphorylation with the
NAD+-linked substrates, while carnitine, hypotaurine and
desferrioxamine did not stabilize significantly. Since taurine
has a high concentration in the tissues, one of its functions
could be protection of oxidative phosphorylation. In view of
experiments by Di Lisa et al. [11], it was a surprise that car-
nitine did not stabilize at a significant level. In one experi-
ment with pyruvate and in another with ascorbate, it was
found to be most effective. In the other experiments it was
not harmful for the oxidative phosphorylation. It was of in-
terest that desferrioxamine had a deleterious effect on
oxidative phosphorylation, because it was found to have a
beneficial effect on the heart during ischemia and reperfusion,
by decreasing the iron dependent hydroxyl production, which
is harmful to oxidative phosphorylation [12, 13]. It is used
in the treatment of iron overload diseases such as porphyria
cutanea tarda, thalassemia and other hematological diseases
which require regular blood transfusion. Desferoxamine has
the disadvantage of many side effects, especially affecting the
lens and the retina of the eye [14] and the kidney tubules [15].
Before patients can be treated with drugs that protect
oxidative phosphorylation, we need to know the best com-
bination of them in vitro, and then the effect on the realiza-
tion and the turnover of the components involved in oxidative
phosphorylation. Maybe the effect on muscle can be tested
in (human) muscle culture, also of patients. In the latter case,
the finding of repair of the defect would be of great help. After
that, when the drugs are known to be safe (several of them
are already tested in other patients), they can be tested on
patients with defects in oxidative phosphorylation. Of course
together with other treatments that proved valuable in indi-
vidual patients [20–24].
With appreciation we refer to work by Kraft et al. [25] who
studied the stability of mitochondria in human muscle fibres.
Their muscle fibre  model is an interesting one, but requires
a high resolution oxygraph.
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Pyruvate + malate Glutamate + malate Palmitoylcarnitine Succinate + rotenone Ascorbate + TMPD n
+ malate
SETH-medium 0.73 ± 0.23 0.52 ± 0.06 0.77 ± 0.14 0.21 ± 0.13 0.15 ± 0.09 6
+ Taurine 0.48 ± 0.24 0.43 ± 0.12 0.60 ± 0.20 0.20 ± 0.12 0.14 ± 0.09 6
+ Carnitine 0.65 ± 0.34 0.49 ± 0.11 0.68 ± 0.22 0.23 ± 0.10 0.12 ± 0.08 6
+ Hypotaurine 0.65 ± 0.30 0.45 ± 0.20 0.93 ± 0.46 0.22 ± 0.16 0.20 ± 0.14 3
+ Desferrioxamine 1.32 ± 0.45 0.63 ± 0.18 1.31 ± 0.68 0.30 ± 0.14 0.20 ± 0.07 3
The decays are given in the average k ± SD and n is the number of independent preparations. When the average decay has been given in bold it is
significantly lower than in the control (SETH-medium). The drugs were added to the mitochondria in SETH-medium in a similar volume of SETH with 2
mM taurine, 10 mM L-carnitine, 2 mM hypotaurine and 0.2 mM desferrioxamine and stored at 0°C in the dark. Final pH 7.4. The protein concentrations
during the incubations were 1.2–2.3 mg per ml. Directly after isolation the average rate of pyruvate + malate oxidation was 164 ± 20 (SD) nmol O2·min–1 (mg
protein)–1 and the stimulation of the oxidation by ADP was 8.0 ± 1.3. The oxygen uptake rates with the other substrates were for palmitoylcarnitine + malate
133 ± 29, glutamate + malate 143 ± 57, succinate + rotenone 161 ± 44 and ascorbate + TMPD + deferoxamine 610 ± 202. These measurements were repeated
after 1 day of storage for the NAD+-linked substrates and after 2 days for the other substrates. The assays were done in duplicate.
